Survival of patients with nonseminomatous germ cell cancer: a review of the IGCC classification by Cox regression and recursive partitioning
暂无分享,去创建一个
E W Steyerberg | J. Habbema | E. Steyerberg | E. Dusseldorp | E Dusseldorp | J D F Habbema | M R van Dijk | S P Stenning | S. Stenning | M. R. van Dijk | EW Steyerberg | J. Habbema | MR van Dijk | SP Stenning
[1] R. Little. Regression with Missing X's: A Review , 2011 .
[2] Alan Horwich,et al. Testicular germ-cell cancer , 2006, The Lancet.
[3] F. Harrell,et al. Prognostic/Clinical Prediction Models: Multivariable Prognostic Models: Issues in Developing Models, Evaluating Assumptions and Adequacy, and Measuring and Reducing Errors , 2005 .
[4] J Schleicher,et al. Treatment-induced anaemia and its potential clinical impact in patients receiving sequential high dose chemotherapy for metastatic testicular cancer , 2002, British Journal of Cancer.
[5] G. Assmann,et al. Simple Scoring Scheme for Calculating the Risk of Acute Coronary Events Based on the 10-Year Follow-Up of the Prospective Cardiovascular Münster (PROCAM) Study , 2002, Circulation.
[6] J. Habbema,et al. Internal validation of predictive models: efficiency of some procedures for logistic regression analysis. , 2001, Journal of clinical epidemiology.
[7] H S Koops,et al. Improved long term survival of patients with metastatic nonseminomatous testicular germ cell carcinoma in relation to prognostic classification systems during the cisplatin era , 2001, Cancer.
[8] C. Meisner,et al. Identification of prognostic subgroups among patients with metastatic 'IGCCCG poor-prognosis' germ-cell cancer: an explorative analysis using cart modeling. , 2000, Annals of oncology : official journal of the European Society for Medical Oncology.
[9] J. Habbema,et al. Prognostic modelling with logistic regression analysis: a comparison of selection and estimation methods in small data sets. , 2000, Statistics in medicine.
[10] J. Richie,et al. The National Cancer Data Base report on patterns of care for testicular carcinoma, 1985–1996 , 1999, Cancer.
[11] C. Meisner,et al. First-line high-dose chemotherapy compared with standard-dose PEB/VIP chemotherapy in patients with advanced germ cell tumors: A multivariate and matched-pair analysis. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[12] H. Boshuizen,et al. Multiple imputation of missing blood pressure covariates in survival analysis. , 1999, Statistics in medicine.
[13] R. Motzer,et al. Risk assessment for metastatic testis cancer. , 1998, The Urologic clinics of North America.
[14] P. Wilkinson,et al. International Germ Cell Consensus Classification: a prognostic factor-based staging system for metastatic germ cell cancers. International Germ Cell Cancer Collaborative Group. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[15] W. Loh,et al. Tree-structured proportional hazards regression modeling. , 1994, Biometrics.
[16] D. Clayton,et al. Statistical Models in Epidemiology , 1993 .
[17] M. LeBlanc,et al. Relative risk trees for censored survival data. , 1992, Biometrics.
[18] P. Grambsch,et al. Martingale-based residuals for survival models , 1990 .
[19] M R Segal,et al. A comparison of estimated proportional hazards models and regression trees. , 1989, Statistics in medicine.
[20] N. Geller,et al. Comparison of criteria for assigning germ cell tumor patients to "good risk" and "poor risk" studies. , 1988, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[21] F. Harrell,et al. Regression modelling strategies for improved prognostic prediction. , 1984, Statistics in medicine.
[22] Douglas G Altman,et al. Developing a prognostic model in the presence of missing data: an ovarian cancer case study. , 2003, Journal of clinical epidemiology.
[23] A. Horwich,et al. The Second Medical Research Council study of prognostic factors in nonseminomatous germ cell tumors. Medical Research Council Testicular Tumour Working Party. , 1992, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[24] N. Geller,et al. Assessment of risk in metastatic testis carcinoma: impact on treatment. , 1991, Urologia internationalis.